REFERENCES

back to Vaccine homepage






Introduction
1. Shann, Frank and Mark C. Steinhoff.  "Vaccines for children in rich and poor countries."  The Lancet.  354: pg. 7, 1999.
 

Measles
1. World Health Organization.  Using Surveillance Data and Outbreak Investigations to Strengthen Measles Immunization Programs.  1996.
2. Redd, Stephen, et al.  Measles Vaccine (eds: Plotkin and Orenstein. Philadelphia: W.B Saunders, 1999).
3. National Institutes of Health.  The Jordan Report: Accelerated Development of Vaccines.  2000 (available on http://www.niaid.nih.gov/publications/pdf/jordan.pdf)
4. Redd, S, 224.

Rotavirus
1. Cunliffe, N.A. Epidemiology of Rotavirus Diarrheoa in Africa: a review to assess the need for rotavirus immunization.  Bulletin of the World Health Organization 76: 525, 1998.
2. Clark Fred, et al.  Rotavirus Vaccines. Vaccines, (eds: Plotkin and Orenstein. Philadelphia: W.B Saunders, 1999).
3. Breese, Joseph.  Current Status and Future Priorities for rotavirus vaccine development, evaluation and implementation in developing countries.  Vaccine 17: 2209, 1999.
4. Clark, F, 988.
5. Weekly Epidemiological Record.  6: 35, 1997.
6. Cunliffe, 527.
7. Clark, F. 988
8. http://www.niaid.nih.gov/publications/datline/0398/rotavirus.htm
9. http://www.cdc.gov.nip/news/rotavirus.htm
10. http://www.aap.org/policy/re9938.html
11. Weekly Epidemiological Record. 6: 35, 1997.
12. Clark, 987.
13. Breese, 2209.
14. Clark, 990.

HIV
1.http://HIVInSite.ucsf.edu/social/un/2098.44d3.html#1
2.Meldorf, Matthew and Lawerence Corey.  "Update on HIV Vaccines".
http://www.weber.u.washington.edu/~vaccine/
3. http://www.brown.edu/Courses/Bio_160/projects/hiv/hiv.html
4. Meldorf, Matthew and Lawerence Corey.  "Update on HIV Vaccines".

Pneumococcus
1.Bill and Melinda Gates Children's Vaccine Program.  Pneumococcus In Depth.  http://www.childrensvaccine.org/html/v_pneumo_id.htm
2. http://search.gallery.yahoo.com/search/corbis?p=%28doctor+physician%29+-witch+-flying+-livingstone&strip=2
3. "Epidemiology and Prevention of Vaccine-Preventable Diseases" course Textbook, January 2000.  Public Health Foundation.  Chapter 16, pg. 250. http://www.cdc.gov/nip/publications/pink/default.htm
4. http://www.vh.org/Providers/TeachingFiles/PulmonaryCoreCurric/InvasivePneumonia/GramStain1.html
5. "Morbidity and Mortality Weekly Report" Centers for Disease Control and Prevention. April 4, 1997.  Vol. 46.  pg. 2 ftp://ftp.cdc.gov/pub/Publications/mmwr/rr/rr4608.pdf
6."Epidemiology and Prevention of Vaccine Preventable Diseases".  pg.252.

Haemophilus Influenzae Type B
1. http://www.ncbi.nlm.nih.gov/Complete_Genomes/Hin/
2. WHO, via http://www.childrensvaccine.org/html/v_hib_id.htm
3. "Epidemiology and Prevention of Vaccine-Preventable Diseases" course Textbook, January 2000.  Public Health Foundation.  Chapter 8,pg102. http://www.cdc.gov/nip/publications/pink/default.htm
4. Bill and Melinda Gates Children's Vaccine Program.  Hib In Depth.  http://www.childrensvaccine.org/html/v_pneumo_id.htm
5. "Epidemiology and Prevention of Vaccine Preventable Diseases". pg.103
6. http://www.vh.org/Providers/Textbooks/ElectricAirway/PathImages/HInfluenzaGramStain.html
7. Bill and Melinda Gates Children's Vaccine Page.  Hib Vaccine Details.  http://www.childrensvaccine.org/html/v_hib_vac.htm

ISSUES
 

Disease Surveillance
1. Levin, Myron, et al. Influence of Disease Burden, Public Perception, and other factors on New Vaccine Development, Implementation, and Continued Use. Lancet 350:1386, 1998.

2.Cutts, Felicity and Jean-Marc Olive.  Vaccination Programs in Developing Countries.  Vaccines, (eds:Plotkin and Orenstein. Philadelphia: W.B Saunders, 1999).
3. Jacob, J and Samuel Reuben. Disease Surveillance at District Level: A Model for Developing Countries.   Lancet 352: 58, 1998.
4. Cutts, F. 1057
5. World Health Organization.  Using surveillance Data and Outbreak Investigations to strengthen Measles immunization Programs. 1996. (available on www.who.org).

The Economics of Vaccine Development and Program Implementation
6. Hughes, James, et al.  Rotavirus Vaccine for the Prevention of Rotavirus Gastroenteritis Among Children: Recommendations of the Advisory Committee on Immunization Practices. MMWR 48: 8, 1999.
7. Cutts, F. 1060.
8. MacNamee, David.  Health Costs. Lancet 342: 105, 1993.
9. World Bank.  World Development Report 1993.  Investing in Health. Oxford, Oxford University Press, 1993.
10. Francis, Donald. HIV Vaccine Development-Progress and Problems. AIDS in the World II, (New York: Oxford University Press, 1996).
11. Abrams, Sarah, ìDesigning HIV Vaccines for Developing Countriesî. Harvard AIDS Review, 1995, 4.
12. Bloom, Barry, ìThe Highest Attainable Standards: Ethical Issues in AIDS Vaccinesî, Science, 279:186, 1998.
13. Francis, 190.
14. Lurie, Peter, et al.  Ethical, Behavioral, and Social Aspects of HIV Vaccine Trials in Developing Countries. Journal of the American Medical Association. 271: 300 (1994) 300.
15. Cutts, F. 1060.
16. World Health Organization.  Building on Success. World Health 51:10,1998
17. Cutts, 300.
18. Hall, Stephen.  Science Triumphs, Market Fails. Technology Review 102: 78, 1999.

Eradication
19. World Health Organization, 10.
20. Cutts, 1065.
21. World Health Organization, 11.
22. National Institutes of Health.  The Jordan Report: Accelerated Development of Vaccines.  2000 (available on http://www.niaid.nih.gov/publications/pdf/jordan.pdf)
23. Cutts, 1064.

Vaccine Supply, Safety, Quality, and Delivery
24. Vaccines Quality Control Deficient.  Lancet 340: 1282, 1992.
25. Stix, Gary. Keeping Vaccines Cold: Travails of immunizing the worldís children. Scientific American 274: 14, 1996.
26.Cutts, 1055.

Increasing Resistance to Antibiotic Drug Therapies
27. Levy, Stuart.  "The Challenge of Antibiotic Resistance." Scientific American. Vol. 398, 1998.
http://www.sciam.com/1998/0398issue/0398levy.html
28. Shann, Frank and Mark C. Steinhoff.  "Vaccines for children in rich and poor countries."  The Lancet.  354: pg. 7, 1999.

Vaccine Studies/Clinical Trials in Developing Countries
West vs. Developing Countries: issues of trust
29.  Studdert, DM and TA Brennan.  "Clinical Trials in developing countries: scientific and ethical issues." Medical Journal of Australia. 169:545-8.  Nov. 16, 1998.
30.  Bishaw, Lurie P. et al. "Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries." Journal of the American Medical Association.  271(4):295-301, Jan. 26, 1994.
 

Diseases
31. United Nations Children's Fund. The State of the World's Children. Oxford Univ. Press: New York, 1997.
32.  Shann, Frank and Mark C. Steinhoff.  "Vaccines for children in rich and poor countries."  The Lancet.  354: pg. 7, 1999.